DKDaniel Kämmer

Daniel Kämmer

*This is an algorithmically generated author record based on publicly available information.

Daniel Kämmer has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Robotic-assisted total knee arthroplasty demonstrates superior early functional outcomes compared with conventional total knee arthroplasty: a quasi-randomised controlled trial

    by Filippo Migliorini, Luise Schäfer, Andrea Nobili, Daniel Kämmer, Jens Schneider, Andreas Bell

    Background: Robotic-assisted total knee arthroplasty (TKA) has gained popularity over the last decade, with claimed advantages in implant positioning accuracy and soft-tissue balance. Whether these technical advantages translate into better clinical outcomes for patients remains debated. This investigation compared 1-year patient-reported outcomes between robotic-assisted and conventional TKA performed within the same institution but following structurally different surgical workflows. Methods: This quasi-randomised controlled trial enrolled patients who underwent primary TKA at the Department of Orthopaedic and Trauam Surgery of the Eifelklink St. Brigida (Simmerath, Germany) between 2022 and 2025. Group allocation was determined by surgeon assignment through the institutional digital scheduling system. All patients received the same implant (Smith & Nephew Legion Genesis II, posterior-stabilised). Robotic-assisted procedures were performed using the CORI Robotic System (Smith & Nephew, UK) following a four-dimensional personalised alignment workflow (coronal, sagittal, transversal and balancing) guided intraoperatively by the Knee Balancing Score (KBS). Conventional procedures followed a femur-first technique with adjusted mechanical alignment. Outcomes included WOMAC total and subscores, visual analogue scale (VAS), Tegner activity score and a dedicated functional questionnaire, all assessed at 1-year follow-up. Results: A total of 845 patients were included (robotic-assisted: n = 390; conventional: n = 455). At 1-year, 383 and 445 patients completed follow-up, respectively. The two groups were comparable at baseline. The robotic-assisted cohort showed significantly better results across WOMAC and related subscales ( P < 0.001), VAS ( P < 0.001), Tegner ( P < 0.001), functional and satisfaction items, including walking distance and knee stability. No difference was found in the use of walking aids. Conclusions: Robotic-assisted TKA was associated with superior functional and patient-reported outcomes at the 1-year follow-up. The clinical benefit observed is likely not attributable to robotic precision alone, but reflects the structured, personalised intraoperative workflow that robotic assistance enables. Trial Registry German Registry of Clinical Trials (ID DRKS00030614).

  • Clarifying allocation, measurement reliability and phenotype reporting in robotic-assisted TKA

    by Filippo Migliorini, Nicola Maffulli, Luise Schäfer, Jens Schneider, Andrea Maria Nobili, Daniel Kämmer, Andreas Bell

  • Antithrombotic prophylaxis following total knee arthroplasty: a level I Bayesian network meta-analysis

    by Filippo Migliorini, Nicola Maffulli, Erlis Velaj, Andreas Bell, Daniel Kämmer, Jörg Eschweiler, Ulf Krister Hofmann

    Introduction Venous thromboembolism (VTE) is a major concern following total knee arthroplasty (TKA). The optimal pharmacological prophylaxis remains, however, controversial. The present investigation compared several non-vitamin K antagonist oral anticoagulants commonly employed as VTE prophylaxis following TKA. A Bayesian network meta-analysis was conducted to compare apixaban, aspirin, dabigatran, edoxaban, enoxaparin, fondaparinux, and rivaroxaban. The outcomes of interest were to compare the rate of deep venous thrombosis (DVT), pulmonary embolism (PE), and major and minor haemorrhages. Methods This study was conducted according to the PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-Analyses of Health Care Interventions. In March 2024, PubMed, Web of Science, and Google Scholar were accessed with no time constraints. All randomised controlled trials (RCTs) comparing two or more drugs for the prevention of VTE following TKA were considered for inclusion. Results Data from 29,678 patients were collected. Of them, 67% (19,884 of 29,678 patients) were women. The mean age of the patients was 66.8 ± 2.8 years, and the mean BMI was 29.2 ± 1.5 kg/m2. There was comparability in age, sex, and BMI at baseline. Apixaban 5 mg, dabigatran 220 mg, and rivaroxaban 10 mg were the most effective in reducing the rate of DVT. Apixaban 5 mg, enoxaparin 60 mg, and rivaroxaban 40 mg were the most effective in reducing the rate of PE. Apixaban 5 mg, rivaroxaban 10 mg, and apixaban 10 mg were associated with the lowest rate of major haemorrhages. Apixaban 5 mg and 20 mg, and dabigatran 220 mg were associated with the lowest rate of minor haemorrhages. Conclusion Administration of apixaban 5 mg demonstrated the best balance between VTE prevention and haemorrhage control following TKA. Level of evidence Level I, network meta-analysis of RCTs.


  • Open Access

    Robotic-assisted total knee arthroplasty in clinical practice: protocol for a randomised controlled trial

    by Filippo Migliorini, Nicola Maffulli, Luise Schäfer, Jens Schneider, Andrea Maria Nobili, Daniel Kämmer, Milosch Michalak, Andreas Bell

    Between 2 and 20% of patients who undergo total knee arthroplasty (TKA) report restricted motion and anterior knee pain. Non-optimal alignment of the implant components is a common cause of such complaints. Robotic-assisted TKA has been advocated to improve the accuracy of component positioning to match patients’ anatomy and biomechanics. However, the advantages of robotic surgery over conventional freehand TKA are still unclear. The present study is a protocol for a single-blind clinical trial in which patients will be randomly allocated to undergo either robotic-assisted TKA or conventional freehand TKA. A restricted kinematic alignment with medial para-stellar approach shall be made in all patients. The present study follows the SPIRIT guidelines. The primary outcome of interest is to compare robotic TKA versus traditional freehand TKA in terms of patient-reported outcome measures (PROMs), length of hospitalisation, blood values, blood transfusion units, and range of motion. The second outcome of interest is to evaluate the accuracy of component positioning of robotic-assisted TKA compared to the conventional freehand TKA.Level of evidence Level I, randomised controlled trial.Registration German Registry of Clinical Trials (ID: DRKS00030614).


  • Open Access

    Management of transient bone osteoporosis: a systematic review

    by Filippo Migliorini, Gianluca Vecchio, Christian David Weber, Daniel Kämmer, Andreas Bell, Nicola Maffulli

    Introduction: Transient bone osteoporosis (TBO) is characterized by persistent pain, loss of function, no history of trauma and magnetic resonance image (MRI) findings of bone marrow edema. Source of data: PubMed, Google scholar, EMABSE and Web of Science were accessed in February 2023. No time constrains were used for the search. Areas of agreement: TBO is rare and misunderstood, typically affecting women during the third trimester of pregnancy or middle-aged men, leading to functional disability for 4–8 weeks followed by self-resolution of the symptoms. Areas of controversy: Given the limited evidence in the current literature, consensus on optimal management is lacking. Growing points: This systematic review investigates current management of TBO. Areas timely for developing research: A conservative approach leads to the resolution of symptoms and MRI findings at midterm follow-up. Administration of bisphosphonates might alleviate pain and accelerate both clinical and imaging recovery.